Open AccessRe-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists
Author(s) -
Bin-Yan Zhong,
Wansheng Wang,
Shen Zhang,
HaiDong Zhu,
Lei Zhang,
Jian Shen,
Xiaoli Zhu,
GaoJun Teng,
Ni Chen
Publication year - 2021
Publication title -
journal of clinical and translational hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.042
H-Index - 29
eISSN - 2310-8819
pISSN - 2225-0719
DOI - 10.14218/jcth.2021.00049
Subject(s) - medicine , refractory period , hepatocellular carcinoma , refractory (planetary science) , clinical practice , gastroenterology , physical therapy , astrobiology , physics
The recognition of transarterial chemoembolization (TACE) failure/refractoriness among Chinese clinicians remains unclear. Using an online survey conducted by the Chinese College of Interventionalists (CCI), the aim of this study was to explore the recognition of TACE failure/refractoriness and review TACE application for hepatocellular carcinoma (HCC) treatment in clinical practice.